SNHG8 and neoplasm: In non-tumor diseases, upregulated SNHG8 serves as a competitive endogenous RNA by sponging miR‐425‐5p, and inhibits the SIRT1/NF‐κB signaling pathway to attenuate the ischemia-induced microglial inflammatory response [21].